1. Home
  2. TDS vs IRTC Comparison

TDS vs IRTC Comparison

Compare TDS & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telephone and Data Systems Inc.

TDS

Telephone and Data Systems Inc.

HOLD

Current Price

$45.11

Market Cap

5.5B

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$127.52

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDS
IRTC
Founded
1968
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.8B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
TDS
IRTC
Price
$45.11
$127.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
13
Target Price
$53.33
$209.69
AVG Volume (30 Days)
859.6K
646.5K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
0.36%
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
N/A
$747,138,000.00
Revenue This Year
$5.28
$18.26
Revenue Next Year
$3.02
$15.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.24
52 Week Low
$31.07
$92.52
52 Week High
$47.80
$210.01

Technical Indicators

Market Signals
Indicator
TDS
IRTC
Relative Strength Index (RSI) 52.33 33.57
Support Level $36.93 N/A
Resistance Level $47.43 $158.52
Average True Range (ATR) 1.46 8.43
MACD -0.25 -1.52
Stochastic Oscillator 43.07 18.56

Price Performance

Historical Comparison
TDS
IRTC

About TDS Telephone and Data Systems Inc.

Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: